Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics
Go back to Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics| (NASDAQ: ANAB) | Delayed: 51.67 +0.43 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.24 | 52 Week High | $ | |||
| Open | $50.81 | 52 Week Low | $ | |||
| Day High | $52.46 | P/E | N/A | |||
| Day Low | $50.67 | EPS | $ | |||
| Volume | 323,966 | |||||
